Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026
Go back to Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026| (NASDAQ: EVAX) | Delayed: 2.96 -0.09 (2.95%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.05 | 52 Week High | $ | |||
| Open | $3.09 | 52 Week Low | $ | |||
| Day High | $3.09 | P/E | N/A | |||
| Day Low | $2.93 | EPS | $ | |||
| Volume | 3,354 | |||||

